NCT06705309Completed
Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer
The Effect of a Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer on Women's Prevention Methods
Source: ClinicalTrials.gov · Last updated 26 Nov 2024
Brief summary (registry, in English)
Cervical cancer is the fourth most common cancer type among women worldwide and ranks ninth in Turkey, making it the second most common gynecological cancer. The prevention of cancer heavily relies on identifying risk factors, implementing preventive measures, and early diagnosis. Cervical cancer is associated with high-risk Human Papilloma Virus (HPV) infections, transmitted primarily through sexual contact, accounting for 99.7% of cases. Risk-enhancing factors include early sexual activity, poor hygiene, low socioeconomic status, and immunosuppressive conditions. The World Health Organization (WHO) launched the "Cervical Cancer Elimination Program" to address this public health issue, aiming for 90% of girls to be vaccinated against HPV by age 15, 70% of women aged 35-45 to be screened, and 90% of women diagnosed with cancer to have access to treatment by 2030. The low participation rate in cervical cancer screening programs in Turkey highlights the urgent need to increase public awareness. Web-based education is an effective tool for promoting health behaviors and increasing awareness. Its cost-effectiveness, ability to reach large audiences, and easy accessibility make it a valuable resource in healthcare. Studies in the literature demonstrate that web-based and video-based education significantly enhance cervical cancer awareness and encourage pap smear test uptake. This study developed a web-based education program and an educational booklet on cervical cancer, based on the Health Belief Model, to evaluate their impact on women's knowledge, attitudes, and behaviors. The study aims to contribute to the dissemination of cervical cancer prevention methods and enrich the existing literature.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 128 (actual)
- First submitted
- 21 Nov 2024
- Start date
- 29 May 2024
- Primary completion date
- 31 Aug 2024
- Lead sponsor
- Istanbul University - Cerrahpasa
- Diseases
- Cervical cancer
- NCT number
- NCT06705309
What you commit to
- Study type: Interventional
- Participants enrolled: 128
- From 29 May 2024 to the primary completion date, 31 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- The emergence of any health problem that prevents the person from continuing the research,
- Not completing any of the required forms,
- Those who give up participating in the study at any stage of the study
- Do not visit 80% of the tabs in the web training program,
- Those who have never read the training booklet will be excluded.
Who the study is looking for
- Being between the ages of 30-65,
- Having never had a cervical cancer screening before,
- Having received training on cervical cancer,
- There is no obstacle to answering the questions physically, mathematically or spiritually,
- Having internet access,
- Being able to use a computer and/or tablet effectively,
- Academicians working in health programs,
- Healthy female academics who did not agree to participate in the research,
- Being able to use a computer
Age in the registry: 30 years to 65 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University - Cerrahpasa Coordinator of this site? Confirm its status | Avcılar | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.